$ACET SEC Filings

Filed On	Filing
23 Oct 2026	SCHEDULE 13G
28 Sep 2026	8-K: Regulation FD Disclosure; Other Events Forward-Looking Statements This presentation contains “forward-looking statements” of Adicet within the meaning of the Private Securities Litigation Reform Act of 1995 relating to the business and operations of Adicet. The words “anticip...
08 Sep 2026	8-K: Regulation FD Disclosure Forward-Looking Statements This presentation contains “forward-looking statements” of Adicet within the meaning of the Private Securities Litigation Reform Act of 1995 relating to the business and operations of Adicet. The words “anticip...
01 Sep 2026	8-K: Regulation FD Disclosure
14 Aug 2026	SCHEDULE 13G/A
07 Aug 2026	Form 4: Klickstein Lloyd, Director Granted 18,300 Stock Option (Right to Buy)
05 Aug 2026	10-Q
05 Aug 2026	8-K: Results of Operations and Financial Condition
23 Jun 2026	Form 4: Aftab Blake, Chief Scientific Officer Granted 55,000 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Schor Chen, Director Granted 55,000 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Dubin Steve, Director Granted 4,200 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Chodakewitz Jeffrey, Director Granted 4,200 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Grissinger Michael, Director Granted 4,200 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Sinclair Andrew, Director Granted 4,200 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Peng Katie, Director Granted 4,200 Stock Option (Right to Buy)
23 Jun 2026	Form 4: Klickstein Lloyd, Director Granted 4,200 Stock Option (Right to Buy)
18 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
20 May 2026	10-K/A
15 May 2026	SCHEDULE 13G/A
13 May 2026	S-8 POS

Comments